Rise Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
2,451
-44
| -2% | -$4.01K | 0.09% | 89 |
|
|
2025
Q1 | $282K | Sell |
2,495
-11
| -0.4% | -$1.25K | 0.12% | 73 |
|
|
2024
Q4 | $265K | Buy |
2,506
+6
| +0.2% | +$634 | 0.13% | 72 |
|
|
2024
Q3 | $270K | Buy |
2,500
+5
| +0.2% | +$540 | 0.13% | 71 |
|
|
2024
Q2 | $271K | Buy |
2,495
+5
| +0.2% | +$543 | 0.14% | 72 |
|
|
2024
Q1 | $329K | Buy |
2,490
+128
| +5% | +$16.9K | 0.18% | 60 |
|
|
2023
Q4 | $287K | Buy |
2,362
+5
| +0.2% | +$609 | 0.2% | 49 |
|
|
2023
Q3 | $265K | Sell |
2,357
-123
| -5% | -$13.8K | 0.21% | 43 |
|
|
2023
Q2 | $361K | Buy |
2,480
+4
| +0.2% | +$582 | 0.28% | 39 |
|
|
2023
Q1 | $320K | Buy |
2,476
+5
| +0.2% | +$646 | 0.24% | 45 |
|
|
2022
Q4 | $315K | Buy |
2,471
+5
| +0.2% | +$637 | 0.25% | 45 |
|
|
2022
Q3 | $258K | Buy |
2,466
+6
| +0.2% | +$628 | 0.21% | 54 |
|
|
2022
Q2 | $258K | Buy |
2,460
+130
| +6% | +$13.6K | 0.26% | 51 |
|
|
2022
Q1 | $298K | Buy |
2,330
+804
| +53% | +$103K | 0.27% | 51 |
|
|
2021
Q4 | $188K | Buy |
+1,526
| New | +$188K | 0.18% | 68 |
|